Significant difference in outcome for adolescents with acute lymphoblastic leukemia treated on pediatric vs adult protocols in the Netherlands

被引：244

作者：

de Bont, JM

van der Holt, B

Dekker, AW

van der Does-van den Berg, A

Sonneveld, P

Pieters, R

机构：

[1] Erasmus MC, Sophia Childrens Hosp, Dept Pediat Oncol & Hematol, NL-3015 GJ Rotterdam, Netherlands

[2] Erasmus MC, Dr Daniel Den Hoed Canc Ctr, Rotterdam, Netherlands

[3] UMC Utrecht, Utrecht, Netherlands

[4] DCOG, The Hague, Netherlands

来源：

LEUKEMIA | 2004年 / 18卷 / 12期

关键词：

D O I：

10.1038/sj.leu.2403538

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2032 / 2035

页数：4

共 9 条

[1] HIGH-DOSE METHOTREXATE IMPROVES CLINICAL OUTCOME IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - ST-JUDE TOTAL THERAPY STUDY [J].

ABROMOWITCH, M ;

OCHS, J ;

PUI, CH ;

KALWINSKY, D ;

RIVERA, GK ;

FAIRCLOUGH, D ;

LOOK, AT ;

HUSTU, HO ;

MURPHY, SB ;

EVANS, WE ;

DAHL, GV ;

BOWMAN, WP .

MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (05) :297-303

[2] Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia [J].

Aricò, M ;

Valsecchi, MG ;

Camitta, B ;

Schrappe, M ;

Chessells, J ;

Baruchel, A ;

Gaynon, P ;

Silverman, L ;

Janka-Schaub, G ;

Kamps, W ;

Pui, CH ;

Masera, G .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :998-1006

[3] Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials [J].

Boissel, N ;

Auclerc, MF ;

Lhéritier, V ;

Perel, Y ;

Thomas, X ;

Leblanc, T ;

Rousselot, P ;

Cayuela, JM ;

Gabert, J ;

Fegueux, N ;

Piguet, C ;

Huguet-Rigal, F ;

Berthou, C ;

Boiron, JM ;

Poutos, C ;

Michel, G ;

Fière, D ;

Leverger, G ;

Dombret, H ;

Baruchel, A .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) :774-780

[4] Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group [J].

Bostrom, BC ;

Sensel, MR ;

Sather, HN ;

Gaynon, PS ;

La, MK ;

Johnston, K ;

Erdmann, GR ;

Gold, S ;

Heerema, NA ;

Hutchinson, RJ ;

Provisor, AJ ;

Trigg, ME .

BLOOD, 2003, 101 (10) :3809-3817

[5] 6-MERCAPTOPURINE CUMULATIVE DOSE - A CRITICAL FACTOR OF MAINTENANCE THERAPY IN AVERAGE RISK CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA [J].

DIBENEDETTO, SP ;

GUARDABASSO, V ;

RAGUSA, R ;

DICATALDO, A ;

MIRAGLIA, V ;

DAMICO, S ;

IPPOLITO, AM .

PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1994, 11 (03) :251-258

[6]

Richards S, 1996, LANCET, V347, P1783

[7] Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01 [J].

Silverman, LB ;

Gelber, RD ;

Dalton, VK ;

Asselin, BL ;

Barr, RD ;

Clavell, LA ;

Hurwitz, CA ;

Moghrabi, A ;

Samson, Y ;

Schorin, MA ;

Arkin, S ;

Declerck, L ;

Cohen, HJ ;

Sallan, SE .

BLOOD, 2001, 97 (05) :1211-1218

[8] Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood [J].

Toyoda, Y ;

Manabe, A ;

Tsuchida, M ;

Hanada, R ;

Ikuta, K ;

Okimoto, Y ;

Ohara, A ;

Ohkawa, Y ;

Mori, T ;

Ishimoto, K ;

Sato, T ;

Kaneko, T ;

Maeda, M ;

Koike, K ;

Shitara, T ;

Hoshi, Y ;

Hosoya, R ;

Tsunematsu, Y ;

Bessho, F ;

Nakazawa, S ;

Saito, T .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (07) :1508-1516

[9] Autologous versus unrelated donor allogeneic marrow transplantation for acute lymphoblastic leukemia [J].

Weisdorf, DJ ;

Billett, AL ;

Hannan, P ;

Ritz, J ;

Sallan, SE ;

Steinbuch, M ;

Ramsay, NKC .

BLOOD, 1997, 90 (08) :2962-2968

← 1 →